Alimera Sciences Company Profile (NASDAQ:ALIM)

Analyst Ratings

Consensus Ratings for Alimera Sciences (NASDAQ:ALIM) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $4.50 (324.53% upside)

Analysts' Ratings History for Alimera Sciences (NASDAQ:ALIM)
Show:
DateFirmActionRatingPrice TargetActions
5/5/2016Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/4/2016Cantor FitzgeraldLower Price TargetBuy$6.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/26/2015Credit Suisse Group AGLower Price Target$5.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2014Summer StreetInitiated CoverageBuy -> Buy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/29/2014Northland SecuritiesBoost Price TargetOutperform$7.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/26/2014 forward)

Earnings

Earnings History for Alimera Sciences (NASDAQ:ALIM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/4/2016Q1($0.19)($0.22)$5.83 million$5.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315($0.21)($0.21)$6.96 million$6.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q215($0.22)($0.25)$6.49 million$5.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115($0.24)($0.27)$3.90 million$3.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/4/2015Q414$0.17($0.28)$5.11 million$1.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q314($0.70)($0.22)$3.75 million$2.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214($0.23)($0.15)$2.70 million$2.19 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014Q114($0.25)($0.20)$1.15 million$2.08 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2014Q413($0.29)($0.24)$0.75 million$0.94 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/11/2013Q313($0.30)($0.26)$0.38 million$0.76 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/12/2013Q2 2013($0.24)($0.30)$3.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2013Q1 2013($0.26)($0.27)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/21/2013Q4 2012($0.23)($0.17)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2012Q312($0.19)($0.17)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2012($0.24)($0.19)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2011($0.19)($0.21)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2011($0.18)($0.17)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2011($0.20)($0.15)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2011($0.22)($0.20)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Alimera Sciences (NASDAQ:ALIM)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Alimera Sciences (NASDAQ:ALIM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Alimera Sciences (NASDAQ:ALIM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
4/21/2016L.P. BavpMajor ShareholderSell478,673$2.59$1,239,763.07View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2015Richard S. Eiswirth, Jr.CFOSell46,669$2.31$107,805.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2015James E FlynnInsiderBuy272,249$3.01$819,469.49View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2015James E FlynnInsiderBuy243,252$3.00$729,756.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2015James E FlynnInsiderBuy16,542$3.00$49,626.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2015James E FlynnInsiderBuy59,342$3.00$178,026.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/26/2015James E FlynnInsiderBuy60,364$3.00$181,092.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/21/2015James E FlynnMajor ShareholderBuy160,684$3.00$482,052.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/20/2015James E FlynnMajor ShareholderBuy100,130$3.00$300,390.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/19/2015James E FlynnMajor ShareholderBuy129,226$2.92$377,339.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/15/2015Richard S. Eiswirth, Jr.CFOSell13,625$2.69$36,651.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/9/2015James E FlynnInsiderBuy321,785$2.42$778,719.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2015Calvin W RobertsDirectorBuy6,424$3.00$19,272.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2015Kenneth GreenSVPSell20,000$3.29$65,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/17/2015Kenneth GreenSVPSell20,000$3.90$78,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/26/2015L.P. BavpMajor ShareholderSell1,024$5.00$5,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2015L.P. BavpMajor ShareholderSell5,568$5.00$27,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2015C. Daniel MyersCEOSell2,000$4.37$8,740.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2015L.P. BavpMajor ShareholderSell3,114$5.02$15,632.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/23/2015L.P. BavpMajor ShareholderSell4,362$5.00$21,810.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/20/2015L.P. BavpMajor ShareholderSell30,300$5.03$152,409.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2015L.P. BavpMajor ShareholderSell35,800$5.03$180,074.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2015L.P. BavpMajor ShareholderSell18,400$5.01$92,184.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/13/2015L.P. BavpMajor ShareholderSell100$5.00$500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2015Richard S Eiswirth JrCFOBuy10,000$4.84$48,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015C. Daniel MyersCEOSell2,000$5.21$10,420.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015C. Daniel MyersCEOSell2,000$5.51$11,020.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015David HollandSVPSell5,000$5.56$27,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014C. Daniel MyersCEOSell2,000$5.99$11,980.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014David HollandSVPSell5,000$5.71$28,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/27/2014L.P. BavpMajor ShareholderSell57,918$6.34$367,200.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014C. Daniel MyersCEOSell2,000$5.42$10,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014David HollandSVPSell5,000$5.26$26,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Patrick LeeMajor ShareholderSell621,191$5.42$3,366,855.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/30/2014Patrick LeeMajor ShareholderSell354,062$5.42$1,919,016.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/29/2014Patrick LeeMajor ShareholderSell240,662$5.47$1,316,421.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2014L.P. BavpMajor ShareholderSell2,816$6.25$17,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2014L.P. BavpMajor ShareholderSell39,500$6.33$250,035.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/29/2014L.P. BavpMajor ShareholderSell7,400$6.27$46,398.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2014L.P. BavpMajor ShareholderSell3,000$6.27$18,810.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014David HollandSVPSell5,000$5.64$28,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014David HollandSVPSell5,000$6.02$30,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014David HollandSVPSell5,000$5.93$29,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2014C. Daniel MyersCEOSell22,775$7.10$161,702.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2014David HollandSVPSell10,000$6.84$68,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2014Susan CaballaInsiderSell8,931$7.01$62,606.31View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2014Domain Partners Vi, L.P.Major ShareholderSell296,760$6.39$1,896,296.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/17/2013Polaris Venture Management CoInsiderSell122,937$4.80$590,097.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2013Domain Partners Vi, L.P.Major ShareholderSell10,516$5.01$52,685.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2013Domain Partners Vi, L.P.Major ShareholderSell55,278$5.39$297,948.42View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2013Polaris Venture Management CoInsiderSell37,063$5.44$201,622.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2013Domain Partners Vi, L.P.Major ShareholderSell126,709$5.29$670,290.61View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/11/2013Domain Partners Vi, L.P.Major ShareholderSell5,337$5.00$26,685.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2013David HollandSVPSell30,000$4.13$123,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2013Domain Partners Vi, L.P.Major ShareholderSell44,242$4.60$203,513.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/13/2012Peter J Pizzo IIIDirectorBuy5,000$1.44$7,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2012C. Daniel MyersCEOSell7,700$1.95$15,015.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Alimera Sciences (NASDAQ:ALIM)
DateHeadline
07/23/16 02:25 PMShares Stumbling of Late: Alimera Sciences, Inc. (NASDAQ:ALIM) - TGP
07/23/16 02:25 PMStock Displaying Signs of a Downtrend: Alimera Sciences, Inc. (NASDAQ:ALIM) - Press Telegraph
07/22/16 10:38 AMIncreased Volatility Noted on Shares of: Alimera Sciences, Inc. (NASDAQ:ALIM) - Engelwood Daily
07/22/16 10:38 AMAlimera Sciences Inc (NASDAQ:ALIM) Stock Technicals Hit Extreme Weakness - CML News
07/22/16 10:38 AMAlimera Sciences Inc. (ALIM) Hits New 52-week Low During July 20 Session - Equities.com
07/22/16 08:04 AMAlimera Sciences (ALIM) Is in Oversold Territory: What's Next? -
07/21/16 02:26 PMAlimera Sciences Inc. (ALIM) Hits New 52-week Low During July 19 Session - Equities.com
07/20/16 11:08 AMETF’s with exposure to Alimera Sciences, Inc. : July 20, 2016 -
07/20/16 10:32 AMHeightened Volatility Spotted on Shares of: Alimera Sciences, Inc. (NASDAQ:ALIM) - Engelwood Daily
07/20/16 10:32 AMStock Moving Lower for the Month; Investor Update on Alimera Sciences, Inc. (NASDAQ:ALIM) - Engelwood Daily
07/20/16 10:32 AMAlimera Sciences, Inc. (NasdaqGM:ALIM) Fundamental Star Rating Report - CML News
07/19/16 02:25 PMStock Falling to a Recent Low: Alimera Sciences, Inc. (NASDAQ:ALIM) - Press Telegraph
07/19/16 02:25 PMAre Analysts Bullish Alimera Sciences Inc (NASDAQ:ALIM) After Last Week? - Consumer Eagle
07/19/16 08:37 AMAlimera Sciences Incorporated (NASDAQ:ALIM) Shorts Decreased by 41.84% After Short Covering - Consumer Eagle
07/18/16 02:28 PMInvestor Watch: Volatility Recap on Shares of: Alimera Sciences, Inc. (NASDAQ:ALIM) - Engelwood Daily
07/17/16 07:12 AMShares Moving Down on the Week: Alimera Sciences, Inc. (NASDAQ:ALIM) - Engelwood Daily
07/16/16 02:26 PMShares Experiencing a Downtrend: Alimera Sciences, Inc. (NASDAQ:ALIM) - TGP
07/16/16 02:26 PMAlimera Sciences Incorporated (NASDAQ:ALIM) Sellers Covered 3.16% of Their Shorts - Consumer Eagle
07/16/16 02:26 PMAlimera Sciences Inc. (ALIM) Hits New 52-week Low During July 13 Session - Equities.com
07/14/16 07:55 PMALIMERA SCIENCES INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
07/14/16 02:28 PMEye on Stock Volatility for: Alimera Sciences, Inc. (NASDAQ:ALIM) - Engelwood Daily
07/13/16 07:57 PMAlimera Sciences Inc. (ALIM) Drops 5.93% on July 12 - Equities.com
07/13/16 02:28 PMShare Volatility Watch for: Alimera Sciences, Inc. (NASDAQ:ALIM) - Engelwood Daily
07/13/16 10:29 AMNew Broker Ratings For Alimera Sciences, Inc. (ALIM) - FTSE News
07/12/16 02:26 PMForm 8-K ALIMERA SCIENCES INC For: Jul 12 - StreetInsider.com
07/12/16 07:36 AMALIMERA SCIENCES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
07/11/16 07:28 PMAlimera Sciences Inc. (ALIM) Jumps 5.47% on July 11 - Equities.com
07/11/16 02:24 PMAlimera Sciences Inc (NASDAQ:ALIM) Institutional Investor Sentiment Is 0.59 - Consumer Eagle
07/09/16 10:30 AMAlimera Sciences Incorporated (NASDAQ:ALIM) Shorts Decreased by 3.16% After Short Covering - Press Telegraph
07/06/16 08:11 PMBrokers Issue Average Price Target Of 9.00 On Alimera Sciences, Inc. (ALIM) - Fiscal Standard
07/06/16 08:11 PMAlimera Sciences Inc. (ALIM) Drops 6.15% on July 05 - Equities.com
07/06/16 02:28 PMShares Heading Higher in Session: Alimera Sciences, Inc. (NASDAQ:ALIM) - Telanagana Press
07/06/16 01:11 PMAlimera Sciences to Present at the Cantor Fitzgerald Conference - [at noodls] - July 6, 2016 ATLANTA, July 06, 2016 (GLOBE NEWSWIRE) -- Alimera Sciences (NASDAQ:ALIM), a leader in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced ...
07/06/16 07:12 AMAlimera Sciences Inc. (ALIM) Jumps 5.69% on July 04 - Equities.com
07/05/16 02:23 PMShare Volatility in Focus: Alimera Sciences, Inc. (NASDAQ:ALIM) - Engelwood Daily
07/05/16 02:23 PMAlimera Sciences, Inc. (ALIM) Broker Price Targets For The Coming Week - Fiscal Standard
07/04/16 07:13 AMHow Many Alimera Sciences Inc (NASDAQ:ALIM)'s Analysts Are Bearish? - Press Telegraph
07/03/16 07:12 AMCompany Stock Lower on the Week Alimera Sciences, Inc. (NASDAQ:ALIM) - Engelwood Daily
07/03/16 07:12 AMAlimera Sciences Inc. (ALIM) Hits New 52-week Low During June 30 Session - Equities.com
07/01/16 02:25 PMTracking Stock Volatility for: Alimera Sciences, Inc. (NASDAQ:ALIM) - Engelwood Daily
06/30/16 07:53 PMShares Moving to a Recent Low: Alimera Sciences, Inc. (NASDAQ:ALIM) - Press Telegraph
06/30/16 02:31 PMUpdate on Stock Volatility for: Alimera Sciences, Inc. (NASDAQ:ALIM) - Engelwood Daily
06/29/16 02:24 PMRecently Issued Stock Ratings For Alimera Sciences, Inc. (ALIM) - Fiscal Standard
06/29/16 02:24 PMAlimera Sciences Inc. (ALIM) Hits New 52-week Low During June 27 Session - Equities.com
06/28/16 07:38 AMALIMERA SCIENCES INC : Submission of Matters to a Vote of Security Holders (form 8-K)
06/27/16 04:03 PMALIMERA SCIENCES INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/27/16 02:46 PMStock Touching a Recent Low: Alimera Sciences, Inc. (NASDAQ:ALIM) - Press Telegraph
06/24/16 02:25 PMShares Dropping to a Recent Low: Alimera Sciences, Inc. (NASDAQ:ALIM) - Press Telegraph
06/23/16 03:52 PMAlimera Sciences Inc. (ALIM) Drops 6.17% on June 21 - Equities.com
06/14/16 07:12 AMAlimera Sciences Inc. (ALIM) Jumps 5.81% on June 13 - Equities.com

Social

About Alimera Sciences

Alimera Sciences logoAlimera Sciences, Inc. (Alimera) is a pharmaceutical company. The Company is engaged in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company operates through two segments: U.S. and International. The Company focuses on diseases affecting the back of the eye or retina. The Company's product is ILUVIEN, which is developed to treat diabetic macular edema (DME). DME is a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness. In the United States, ILUVIEN is indicated for the treatment of DME in patients who have been treated with a course of corticosteroids and did not have a rise in intraocular pressure (IOP). In the European Economic Area (EEA) countries, ILUVIEN is indicated for the treatment of vision impairment associated with DME considered insufficiently responsive to available therapies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ALIM
  • CUSIP:
Key Metrics:
  • Previous Close: $1.06
  • 50 Day Moving Average: $1.40
  • 200 Day Moving Average: $1.82
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $47.80M
  • Beta: 2
  • Current Year EPS Consensus Estimate: $-0.72 EPS
  • Next Year EPS Consensus Estimate: $-0.10 EPS
Additional Links:
Alimera Sciences (NASDAQ:ALIM) Chart for Tuesday, July, 26, 2016